Showing results (401-410 of 645) with videos related to

Sort By:
Pageof 65
Journal of the American College of Cardiology|November 1, 1987
Thrombolytic therapy for unstable angina pectoris: rationale and resultsH K Gold, J A Johns, R C Leinbach, et al.
Thrombosis and Haemostasis|December 22, 1988
Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2M C Alessi, I Juhan-Vague, T Kooistra, et al.
Thrombosis and Haemostasis|August 26, 1998
Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass graftingE Moor, A Silveira, F van't Hooft, et al.
Lancet (London, England)|July 4, 1987
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarctionA Hamsten, U de Faire, G Walldius, et al.
Journal of Internal Medicine|January 1, 1997
Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study in Stockholm (APSIS). A comparison with healthy controlsC Held, P Hjemdahl, N Rehnqvist, et al.
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
On the role of plasminogen activator inhibitor-1 in adipose tissue development and insulin resistance in miceH R Lijnen, M-C Alessi, B Van Hoef, et al.
Thrombosis and Haemostasis|September 7, 1992
Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis modelY Imura, J M Stassen, I Vreys, et al.
Journal of Cardiovascular Pharmacology|December 16, 2000
tPA, but not uPA, significantly affects antithrombotic therapy by a glycoprotein IIb/IIIa antagonist, but not by a factor Xa inhibitorM Nishida, H Matsuno, O Kozawa, et al.
The Journal of Biological Chemistry|July 25, 1990
Biochemical and functional characterization of human tissue-type plasminogen activator variants with mutagenized kringle domainsD Collen, H R Lijnen, F Bulens, et al.
Thrombosis and Haemostasis|December 2, 1991
Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activatorT Kurokawa, S Iwasa, A Kakinuma, et al.
Pageof 65